Its likely to be the same story for retatrutide, because thats how its been taken in clinical trials
PCOS is closely linked to insulin resistance, obesity, hormonal imbalance, and chronic inflammation, all areas where semaglutide shows strong benefits
Vegetarian & vegan friendly, dietary supplement
In my opinion, just that one panel Figure 1H from the paper (far right) should have made headlines
The GLP-1 receptor agonist class includes several medications: Semaglutide (brand names Wegovy for weight loss, Ozempic for diabetes) Liraglutide (brand names Saxenda for weight loss, Victoza for diabetes) Tirzepatide (brand name Zepbound for weight loss, Mounjaro for diabetes), which is technically a dual GIP/GLP-1 receptor agonist Dulaglutide (Trulicity, for diabetes) Tirzepatide deserves special mention because it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors